Your Title Goes Here

YOUR CLINICAL PARTNERS IN INNOVATION

About CPI

Clinical Projects International is an innovative clinical research and development organization (CRDO) providing product development services for the pharmaceutical and cosmetics industries across our international sites.

How we do it

We work as a full strategic partner to offer superior clinical results from early development to the pre-commercial phases. We manage every stage of the process from product development to successful Phase I to III clinical trials. With a well-integrated local presence in Europe and the Americas, our aim is to bring our partners’ products to market in the most efficient and cost-effective manner.

Our pragmatic solutions are based on empowering our teams of experienced specialists with modern technology and novel approaches. Our constant objectives are to improve and to accelerate our partners’ product development and validation with efficiency and integrity.

MEDICAL DEVELOPMENT AND CLINICAL TRIALS

Our Medical Development and Clinical Trials operations follow a disciplined approach starting with the elaboration of complete scientific dossiers to ensure successful application to regulatory agencies. CPI has developed its proprietary data control system (Xaveris) to endure a consistent reporting through all in-country sites.  Our team of medical writers and analysts are dedicated to the completion of study reports and publication in scientific journals.

MEDICAL RESEARCH AND DEVELOPMENT

  • Safety and pharmacovigilance

  • Review of Pre-Clinical studies

  • Development of Investigator Brochure

  • Development of Safety Update Report

  • Development Scientific Data

  • Elaboration of Briefing Book and CMC Dossier

  • Chemistry, manufacturing and control (CMC) documents, including quality overall summaries (QOS)

CLINICAL MANAGEMENT

  • Study design 

  • Protocol development 

  • Financial management

  • Design of Data and eCRF Management System

  • Regulatory Project management

  • Regulatory product strategy development

  • Patient information sheets

  • Submission of Clinical Trial Application

MONITORING AND

CLINICAL TRIALS MANAGEMENT

  • Project management

  • Study team set-up

  • Operational guidelines and manuals

  • Vendor selection and management

  • Site contract negotiations and management

  • Investigator and CRA meetings

  • Patient recruitment and retention .

  • On-site and centralized monitoring

  • Source data verification of eCRF

  • Review of trial data to ensure consistent data

MEDICAL WRITING AND REPORTING

  • Data cleaning and database lock

  • Verification Data sets

  • Statistical programming and analysis

  • Study report and submissions

  • Report writing

  • Safety narratives

  • Development Safety Update Reports

  • Updating Investigator’s Brochures

  • Communication Management of study results

CPI facilitates bringing safe, novel life saving and lifestyle altering medication to the people who need them most.

  • We test the medication for safety

  • We perform unbiased Clinical trials to prove their efficacy

  • We ensure standardised production

MEDICAL PIPELINE

CPI in collaboration with Cesa Alliance is testing and developing an increasing number of game changing medications.

OMNIVIROL

There are thousands of viral infections. Most of them will be handled by the immunity system. Some are more persistent or have mild to serious symptoms. Several will return year after year (HSV or Cold sores) other can persist so long they cause cancer (HPV or Papilloma) and others indirectly kill older patients (Influenza or even common cold, turning into Pneumonia) There are no effective anti-virals that can de-activate these viruses.

Our Client Virucease has designed four Omni-spectrum anti-viral drugs that deactivate viruses outside the cells preventing the virus entering the host cells. Because of this feature, viral replication of nearly all viruses can be blocked without the patient experiencing any form of noticeable side effects.

COVID-19 infected patients have been treated with a 3- step dose of Omnivirol and where symptom free in less than 24 hours. Larger Clinical trial protocols are in the making.

RELUMINOL

Tau and Beta – amyloid are 2 proteins known as cerebral plaque slowing down neuro transmitters. This causes lapses of memory which become more and more frequent until the patient is incapable of taking care of himself. This is referred to Alzheimers disease.

RELUMINOL is designed to clear this plaque freeing up the neuro transmitters and regaining the patients access to his memory.

RHEUMARTHRIDOL

Rheumatoid arthritis is a chronic inflammatory disorder that can affect more than just your joints. In some people, the condition can damage a wide variety of body systems, including the skin, eyes, lungs, heart and blood vessels.

The underlining cause is a faulty immunity response. RHEUMARTHRIDOL regulates this immunity response, slowing down or even stopping the inflammation

INFRASTRUCTURE

CPI operates through a network of interconnected facilities in Belgium, Spain, Mexico, and in the United States.

FACILITIES

Our facilities range from administrative offices and data centers to laboratories and research centers equipped with state-of-the-art clean rooms. Our control operations and virology center will be housed in the center of Antwerp supporting our research and production facilities in scientific parks in Niel (Belgium) and Queretaro (Mexico).  

 

For general inquiries, please contact:

info@cpi-medical.com

ANTWERP VIROLOGY CENTER

Antwerp, Belgium

NIEL TECHNOLOGY PARK

Niel, Belgium

CPI MEDICAL SPAIN

Malaga, Spain

MEXICO CORPORATE

Juriquilla, Querétaro, México

MEXICO LABORATORY AND RESEARCH

Querétaro, México

Leave a Message

1 + 5 =